EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT OF CONSECUTIVE NON-SELECTED GLIOBLASTOMA PATIENTS RECEIVING STANDARD THERAPY

Glioblastoma is treated by standard with maximal surgical resection followed by radiation therapy with concomitant and adjuvant temozolomide. Still, median overall survival (OS) for glioblastoma is around 15 months, although the prognosis varies greatly. To improve the treatment, stratification of g...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Regner Michaelsen, Signe, Urup, Thomas, Grunnet, Kirsten, Jarle Christensen, Ib, Lassen, Ulrik, Skovgaard Poulsen, Hans
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Epidemiology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847771/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.313
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料